BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 214545)

  • 1. Evidence suggesting denervation supersensitivity of nigral GABA receptors following destruction of the striatonigral GABA pathway in the rat [proceedings].
    Cross AJ; Waddington JL
    J Physiol; 1978 Sep; 282():30P-31P. PubMed ID: 214545
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioural and neurochemical studies on the striatonigral GABA pathway [proceedings].
    Cross AJ; Waddington JL
    Br J Pharmacol; 1979 Jul; 66(3):477P-478P. PubMed ID: 526755
    [No Abstract]   [Full Text] [Related]  

  • 3. Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]?
    Arbuthnott GW; Garcia-Munoz M; Nicolaou NM; Tulloch IF; Wright AK
    Br J Pharmacol; 1976 Oct; 58(2):272P. PubMed ID: 974393
    [No Abstract]   [Full Text] [Related]  

  • 4. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotational behaviour and striatal dopamine metabolism following unilateral activation of nigral GABA mechanisms: GABA-like modulation of dopaminergic and non-dopaminergic neurons in rat substantia nigra [proceedings].
    Waddington JL
    Br J Pharmacol; 1978 Jun; 63(2):384P. PubMed ID: 566600
    [No Abstract]   [Full Text] [Related]  

  • 6. Denervation supersensitivity in the striatonigral GABA pathway.
    Waddington JL; Cross AJ
    Nature; 1978 Dec; 276(5688):618-20. PubMed ID: 214712
    [No Abstract]   [Full Text] [Related]  

  • 7. Innervation of the substantia nigra.
    Misgeld U
    Cell Tissue Res; 2004 Oct; 318(1):107-14. PubMed ID: 15338269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of manipulating pallidal and nigral GABA on striatally-mediated head-turning in the rat [proceedings].
    Crossman AR; Lee LA; Slater P
    Br J Pharmacol; 1977 Nov; 61(3):483P. PubMed ID: 563262
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase in nigral type II benzodiazepine recognition sites following striatonigral denervation.
    Porceddu ML; Corda MG; Sanna E; Biggio G
    Eur J Pharmacol; 1985 Jun; 112(2):265-7. PubMed ID: 2993000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the substantia nigra in GABA-mediated anticonvulsant actions.
    Gale K
    Adv Neurol; 1986; 44():343-64. PubMed ID: 3010676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of seizure control mediated by gamma-aminobutyric acid: role of the substantia nigra.
    Gale K
    Fed Proc; 1985 May; 44(8):2414-24. PubMed ID: 2985454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single unit responses of substantia nigra and globus pallidus neurons to GABA agonist and antagonist drugs.
    Waszczak BL; Bergstrom DA; Walters JR
    Adv Biochem Psychopharmacol; 1981; 30():79-94. PubMed ID: 7331938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalamic mediation of impulses arriving from the substantia nigra.
    Harasiewicz A; Kolasiewicz W
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):421-9. PubMed ID: 6276873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colocalization of excitatory and inhibitory neurotransmitter markers in striatal projection neurons in the rat.
    White LE; Hodges HD; Carnes KM; Price JL; Dubinsky JM
    J Comp Neurol; 1994 Jan; 339(3):328-40. PubMed ID: 7907614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
    Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
    Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobiochemical changes in tardive dyskinesia.
    Gunne LM; Häggström JE; Johansson P; Levin ED; Terenius L
    Encephale; 1988 Sep; 14 Spec No():167-73. PubMed ID: 2463901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constraints on inferring neurochemical involvement in behavior.
    Dismukes RK
    Neurosci Res Program Bull; 1978 Dec; 16(4):580-4. PubMed ID: 35765
    [No Abstract]   [Full Text] [Related]  

  • 20. Roles of GABA and glycine in the substantia nigra.
    Pycock CJ; Dawbarn D; Kerwin RW
    Adv Biochem Psychopharmacol; 1981; 29():77-87. PubMed ID: 6114627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.